Cerus Corporation (CERS)
USD 1.29
(-7.86%)
USD 1.29
(-7.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -26.53 Million USD | -59.49% |
| 2022 | -34.08 Million USD | 30.36% |
| 2021 | -45.98 Million USD | 16.11% |
| 2020 | -51.37 Million USD | 11.92% |
| 2019 | -64.61 Million USD | -20.44% |
| 2018 | -51.88 Million USD | 4.08% |
| 2017 | -51.86 Million USD | 5.93% |
| 2016 | -58.46 Million USD | -0.24% |
| 2015 | -56.13 Million USD | -37.73% |
| 2014 | -36.54 Million USD | -57.12% |
| 2013 | -42.04 Million USD | -64.33% |
| 2012 | -14.38 Million USD | -13.97% |
| 2011 | -15.09 Million USD | -0.48% |
| 2010 | -15.37 Million USD | 32.59% |
| 2009 | -22.91 Million USD | 25.86% |
| 2008 | -28.53 Million USD | 9.3% |
| 2007 | -43.16 Million USD | -275.88% |
| 2006 | -4.06 Million USD | 71.53% |
| 2005 | -8.68 Million USD | -62.15% |
| 2004 | -23.01 Million USD | 62.45% |
| 2003 | -50.54 Million USD | 10.98% |
| 2002 | -56.78 Million USD | -7.77% |
| 2001 | -52.68 Million USD | -33.38% |
| 2000 | -39.5 Million USD | -62.55% |
| 1999 | -24.29 Million USD | 22.12% |
| 1998 | -29.99 Million USD | -90.24% |
| 1997 | -15.2 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -12.37 Million USD | -533.03% |
| 2024 Q3 | -961 Thousand USD | 93.84% |
| 2024 Q2 | -8.79 Million USD | 55.25% |
| 2023 Q4 | -4.95 Million USD | -81.16% |
| 2023 Q1 | -14.14 Million USD | -42.16% |
| 2023 FY | - USD | -59.49% |
| 2023 Q2 | -7.38 Million USD | 47.8% |
| 2023 Q3 | -2.73 Million USD | 62.99% |
| 2022 Q4 | -9.95 Million USD | -51.37% |
| 2022 FY | - USD | 30.36% |
| 2022 Q2 | -6.1 Million USD | 37.5% |
| 2022 Q3 | -6.57 Million USD | -7.72% |
| 2022 Q1 | -9.76 Million USD | -40.26% |
| 2021 Q2 | -13.28 Million USD | 12.57% |
| 2021 FY | - USD | 16.11% |
| 2021 Q4 | -6.96 Million USD | 31.45% |
| 2021 Q3 | -10.15 Million USD | 23.56% |
| 2021 Q1 | -15.19 Million USD | -5.97% |
| 2020 Q4 | -14.34 Million USD | -11.86% |
| 2020 Q2 | -14.6 Million USD | -0.43% |
| 2020 Q3 | -12.82 Million USD | 12.23% |
| 2020 FY | - USD | 11.92% |
| 2020 Q1 | -14.54 Million USD | 11.35% |
| 2019 Q4 | -16.4 Million USD | 1.29% |
| 2019 Q1 | -14.91 Million USD | 3.5% |
| 2019 FY | - USD | -20.44% |
| 2019 Q2 | -16.79 Million USD | -12.58% |
| 2019 Q3 | -16.62 Million USD | 1.02% |
| 2018 Q3 | -12.77 Million USD | -8.66% |
| 2018 Q2 | -11.75 Million USD | 6.81% |
| 2018 Q4 | -15.45 Million USD | -21.05% |
| 2018 Q1 | -12.61 Million USD | -16.77% |
| 2018 FY | - USD | 4.08% |
| 2017 Q2 | -12.25 Million USD | 30.03% |
| 2017 Q1 | -17.51 Million USD | -18.74% |
| 2017 Q3 | -11.82 Million USD | 3.54% |
| 2017 Q4 | -10.8 Million USD | 8.65% |
| 2017 FY | - USD | 5.93% |
| 2016 Q1 | -15.29 Million USD | -2.6% |
| 2016 Q2 | -16.13 Million USD | -5.51% |
| 2016 Q3 | -14.2 Million USD | 11.95% |
| 2016 Q4 | -14.75 Million USD | -3.83% |
| 2016 FY | - USD | -0.24% |
| 2015 FY | - USD | -37.73% |
| 2015 Q4 | -14.9 Million USD | 7.58% |
| 2015 Q3 | -16.12 Million USD | -6.77% |
| 2015 Q2 | -15.1 Million USD | -5.48% |
| 2015 Q1 | -14.32 Million USD | -12.55% |
| 2014 Q3 | -11.3 Million USD | -3.18% |
| 2014 Q1 | -9.16 Million USD | -18.23% |
| 2014 FY | - USD | -57.12% |
| 2014 Q4 | -12.72 Million USD | -12.59% |
| 2014 Q2 | -10.95 Million USD | -19.46% |
| 2013 Q1 | -4.91 Million USD | -38.43% |
| 2013 Q4 | -7.75 Million USD | 7.4% |
| 2013 Q3 | -8.37 Million USD | -18.68% |
| 2013 Q2 | -7.05 Million USD | -43.73% |
| 2013 FY | - USD | -64.33% |
| 2012 FY | - USD | -13.97% |
| 2012 Q4 | -3.54 Million USD | 31.15% |
| 2012 Q3 | -5.15 Million USD | 32.57% |
| 2012 Q2 | -7.64 Million USD | -68.95% |
| 2012 Q1 | -4.52 Million USD | -31.91% |
| 2011 Q2 | -4.59 Million USD | -16.41% |
| 2011 Q3 | -2.4 Million USD | 47.6% |
| 2011 Q4 | -3.42 Million USD | -42.54% |
| 2011 FY | - USD | -0.48% |
| 2011 Q1 | -3.94 Million USD | 42.85% |
| 2010 FY | - USD | 32.59% |
| 2010 Q2 | -1.48 Million USD | 62.44% |
| 2010 Q1 | -3.95 Million USD | 19.43% |
| 2010 Q4 | -6.89 Million USD | -91.11% |
| 2010 Q3 | -3.61 Million USD | -142.93% |
| 2009 Q1 | -5.81 Million USD | 16.37% |
| 2009 Q3 | -6.17 Million USD | -43.41% |
| 2009 Q2 | -4.3 Million USD | 26.04% |
| 2009 Q4 | -4.91 Million USD | 20.43% |
| 2009 FY | - USD | 25.86% |
| 2008 Q3 | -7.39 Million USD | 17.92% |
| 2008 FY | - USD | 9.3% |
| 2008 Q4 | -6.95 Million USD | 5.91% |
| 2008 Q2 | -9 Million USD | -38.16% |
| 2008 Q1 | -6.52 Million USD | -14.59% |
| 2007 Q3 | -10.31 Million USD | -11.47% |
| 2007 Q1 | -7.68 Million USD | -429.18% |
| 2007 Q4 | -5.69 Million USD | 44.84% |
| 2007 FY | - USD | -275.88% |
| 2007 Q2 | -9.25 Million USD | -20.45% |
| 2006 FY | - USD | 71.53% |
| 2006 Q3 | -2.51 Million USD | 56.27% |
| 2006 Q4 | 2.33 Million USD | 192.66% |
| 2006 Q1 | -2.81 Million USD | 11.91% |
| 2006 Q2 | -5.76 Million USD | -104.33% |
| 2005 Q1 | -22.96 Million USD | -444.53% |
| 2005 Q2 | -2.84 Million USD | 87.6% |
| 2005 Q3 | -1.76 Million USD | 37.9% |
| 2005 FY | - USD | -62.15% |
| 2005 Q4 | -3.2 Million USD | -81.0% |
| 2004 Q1 | -7.24 Million USD | 11.68% |
| 2004 Q2 | -4.59 Million USD | 36.56% |
| 2004 Q3 | -2.92 Million USD | 36.26% |
| 2004 Q4 | -4.21 Million USD | -44.02% |
| 2004 FY | - USD | 62.45% |
| 2003 Q3 | -12.29 Million USD | 16.65% |
| 2003 Q2 | -14.75 Million USD | 3.59% |
| 2003 Q4 | -8.2 Million USD | 33.3% |
| 2003 Q1 | -15.3 Million USD | 0.07% |
| 2003 FY | - USD | 10.98% |
| 2002 Q3 | -16.28 Million USD | -44.18% |
| 2002 Q1 | -13.89 Million USD | 1.43% |
| 2002 FY | - USD | -7.77% |
| 2002 Q2 | -11.29 Million USD | 18.68% |
| 2002 Q4 | -15.31 Million USD | 5.99% |
| 2001 Q2 | -12.89 Million USD | -7.67% |
| 2001 FY | - USD | -33.38% |
| 2001 Q4 | -14.09 Million USD | -2.64% |
| 2001 Q3 | -13.72 Million USD | -6.5% |
| 2001 Q1 | -11.97 Million USD | 1.93% |
| 2000 FY | - USD | -62.55% |
| 2000 Q1 | -8.03 Million USD | -7.13% |
| 2000 Q4 | -12.2 Million USD | -20.65% |
| 2000 Q3 | -10.11 Million USD | -10.76% |
| 2000 Q2 | -9.13 Million USD | -13.7% |
| 1999 Q3 | -6 Million USD | 3.23% |
| 1999 Q1 | -4.6 Million USD | 24.62% |
| 1999 FY | - USD | 22.12% |
| 1999 Q4 | -7.5 Million USD | -25.0% |
| 1999 Q2 | -6.2 Million USD | -26.53% |
| 1998 Q2 | -13.9 Million USD | -255.0% |
| 1998 Q1 | -3.7 Million USD | 18.37% |
| 1998 FY | - USD | -90.24% |
| 1998 Q3 | -6.2 Million USD | 54.23% |
| 1998 Q4 | -6.2 Million USD | 0.0% |
| 1997 Q3 | -2 Million USD | 52.08% |
| 1997 Q2 | -4.4 Million USD | -9.09% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | -4.2 Million USD | 0.0% |
| 1997 Q4 | -4.6 Million USD | -113.04% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -96.752% |
| OrthoPediatrics Corp. | -8.38 Million USD | -216.621% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -152.856% |
| Talis Biomedical Corporation | -66.04 Million USD | 59.821% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -59.136% |
| Inogen, Inc. | -45.67 Million USD | 41.908% |
| Spectral AI, Inc. | -12.26 Million USD | -116.408% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 44.361% |
| CVRx, Inc. | -38.73 Million USD | 31.486% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -652.154% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -119.179% |
| Orthofix Medical Inc. | -86.98 Million USD | 69.494% |
| Venus Concept Inc. | -26.11 Million USD | -1.62% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 46.684% |
| Bioventus Inc. | -23.07 Million USD | -15.024% |
| BrainsWay Ltd. | -2.31 Million USD | -1048.248% |
| Envoy Medical, Inc. | -18.23 Million USD | -45.498% |
| electroCore, Inc. | -17.76 Million USD | -49.414% |
| IceCure Medical Ltd | -15.25 Million USD | -73.972% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 46.662% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -57.43% |
| MaxCyte, Inc. | -44.12 Million USD | 39.866% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -125.723% |
| Nexalin Technology, Inc. | -5.69 Million USD | -366.195% |
| PAVmed Inc | -75.74 Million USD | 64.965% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 50.638% |
| RxSight, Inc. | -41.03 Million USD | 35.336% |
| Sight Sciences, Inc. | -49.41 Million USD | 46.3% |
| SI-BONE, Inc. | -34.44 Million USD | 22.963% |
| TELA Bio, Inc. | -40.63 Million USD | 34.693% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 54.482% |
| Treace Medical Concepts, Inc. | -39 Million USD | 31.973% |
| LivaNova PLC | 39.01 Million USD | 168.013% |
| 908 Devices Inc. | -34.02 Million USD | 22.01% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 76.005% |
| Nemaura Medical Inc. | -7.28 Million USD | -264.152% |
| NeuroPace, Inc. | -22.83 Million USD | -16.213% |
| LENSAR, Inc. | -8.71 Million USD | -204.521% |
| Apyx Medical Corporation | -18.11 Million USD | -46.511% |
| Cutera, Inc. | -136.56 Million USD | 80.568% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -685.089% |
| BioSig Technologies, Inc. | -28.15 Million USD | 5.737% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1154.69% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -26.428% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 106.918% |
| Axonics, Inc. | 7.77 Million USD | 441.299% |
| Outset Medical, Inc. | -153.78 Million USD | 82.745% |
| IRIDEX Corporation | -7.44 Million USD | -256.284% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 72.949% |
| IRadimed Corporation | 20.8 Million USD | 227.573% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -229.149% |
| INVO Bioscience, Inc. | -6.88 Million USD | -285.696% |
| Telesis Bio, Inc. | -40.49 Million USD | 34.468% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 172.351% |
| Varex Imaging Corporation | 67.2 Million USD | 139.488% |
| Quipt Home Medical Corp. | 44.07 Million USD | 160.212% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -144.121% |
| Pulmonx Corporation | -55.09 Million USD | 51.833% |
| Dynatronics Corporation | -976 Thousand USD | -2618.83% |
| Modular Medical, Inc. | -17.1 Million USD | -55.154% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -83.196% |
| Semler Scientific, Inc. | 23.58 Million USD | 212.493% |
| InMode Ltd. | 196.28 Million USD | 113.519% |
| Bruker Corporation | 599 Million USD | 104.43% |
| Cytosorbents Corporation | -28.81 Million USD | 7.896% |
| DexCom, Inc. | 916.7 Million USD | 102.895% |
| Align Technology, Inc. | 799.03 Million USD | 103.321% |
| Viveve Medical, Inc. | -20.61 Million USD | -28.709% |
| ZimVie Inc. | 91.07 Million USD | 129.137% |
| Movano Inc. | -29.12 Million USD | 8.889% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -501.997% |
| Nexalin Technology, Inc. | -5.69 Million USD | -366.195% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -652.154% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 86.368% |
| Profound Medical Corp. | -27.12 Million USD | 2.166% |
| Insulet Corporation | 323.6 Million USD | 108.2% |
| enVVeno Medical Corporation | -25.01 Million USD | -6.068% |
| Surmodics, Inc. | 1.18 Million USD | 2333.67% |
| iCAD, Inc. | -6.56 Million USD | -304.204% |
| Nuwellis, Inc. | -16.35 Million USD | -62.24% |
| Biotricity, Inc. | -8.82 Million USD | -200.58% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 72.604% |
| Aethlon Medical, Inc. | -11.84 Million USD | -123.949% |
| InspireMD, Inc. | -20.91 Million USD | -26.9% |
| PAVmed Inc. | -75.74 Million USD | 64.965% |
| BIOLASE, Inc. | -15.13 Million USD | -75.282% |
| Beyond Air, Inc. | -59.03 Million USD | 55.047% |
| FONAR Corporation | 28.25 Million USD | 193.928% |
| AxoGen, Inc. | -13.32 Million USD | -99.1% |
| Vivani Medical, Inc. | -26.6 Million USD | 0.271% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 208.129% |
| Inari Medical, Inc. | 7.11 Million USD | 473.063% |
| UFP Technologies, Inc. | 72.74 Million USD | 136.479% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -683.747% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -331.059% |
| Tenon Medical, Inc. | -15.52 Million USD | -70.891% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -73.824% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 36.02% |
| AdaptHealth Corp. | -171.09 Million USD | 84.49% |
| Sintx Technologies, Inc. | -6.6 Million USD | -302.061% |
| NanoVibronix, Inc. | -3.43 Million USD | -672.518% |
| Quanterix Corporation | -38.08 Million USD | 30.33% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -144.121% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 88553.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 90.43% |
| TransMedics Group, Inc. | -7.6 Million USD | -249.02% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -21.921% |
| NeuroMetrix, Inc. | -7.09 Million USD | -273.967% |
| Hyperfine, Inc. | -47.06 Million USD | 43.614% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 54.489% |
| Biomerica, Inc. | -5.99 Million USD | -342.783% |
| Bone Biologics Corporation | 479.57 Thousand USD | 5633.267% |
| AVITA Medical, Inc. | -39.56 Million USD | 32.935% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -189.286% |
| Silk Road Medical, Inc | -45.08 Million USD | 41.136% |